RAGE inhibitors like FPS-ZM1 and Azeliragon have shown promise in reducing amyloid deposition and improving cognitive outcomes in transgenic mouse models of AD and in clinical trials [62]. The gene discussed is AGER; the disease is Alzheimer disease.